Venture Capital Firms Invest in Molecular Imprints

Molecular Imprints, Inc. (MII), the leading manufacturer of step and flash imprint lithography (S-FIL™) equipment, announce today that Lux Capital, a venture capital firm focused on making early-stage investments in nanotechnology and related growth sectors, and Harris & Harris Group Inc. (US$2million), a publicly traded venture capital company that makes initial investments exclusively in tiny technology, including nanotechnology, microsystems, and MEMs, are investors in MII’s Series B funding round.

The nanotech venture capital firms join existing top-tier investors including Draper Fisher Jurvetson, Alloy Ventures, Motorola and KLA-Tencor.

“Molecular Imprints is proud to have Harris & Harris Group and Lux Capital as Series B investors,” says Dr. Norman Schumaker, President and CEO of MII. “Their understanding and expertise in the rapidly developing nanotechnology field ideally complements MII’s objective of pushing lithography into the sub-50 nanometer regime.”

“The semiconductor industry has turned to nanoimprint lithography to help preserve Moore’s Law and pattern ever smaller feature sizes onto chips,” says Robert Paull, Managing Partner of Lux Capital. “Molecular Imprints’ unique S-FIL process helped put the technology on the semiconductor roadmap. Their exceptional management team and broad base of industry support now put them in position to dominate this burgeoning market.

For more information on semiconductors, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit